CAJ | 학술논문

目前，冠心病治疗手段主要是药物治疗、经皮冠状动脉介入术、冠状动脉旁路移植术等。临床上冠状动脉多支狭窄患者多选择微创介入治疗，但尤其多支血管病变合并其他疾病患者根据SYNTAX积分或指南，多推荐冠状动脉旁路移植术。然而，心脏外科手术创伤及并发症等缺点，经皮冠状动脉介入术也存在血管再狭窄、血栓等事件风险，随着医学技术不断进步，杂交冠状动脉血运重建术孕育而生，现就杂交冠状动脉血运重建术的定义、手术策略及患者选择、新研究进展做一综述。
목전，관심병치료수단주요시약물치료、경피관상동맥개입술、관상동맥방로이식술등。림상상관상동맥다지협착환자다선택미창개입치료，단우기다지혈관병변합병기타질병환자근거SYNTAX적분혹지남，다추천관상동맥방로이식술。연이，심장외과수술창상급병발증등결점，경피관상동맥개입술야존재혈관재협착、혈전등사건풍험，수착의학기술불단진보，잡교관상동맥혈운중건술잉육이생，현취잡교관상동맥혈운중건술적정의、수술책략급환자선택、신연구진전주일종술。
Currently,treatment strategy of coronary heart disease mainly includes drug therapy, percutaneous coronary intervention ( PCI) , and coronary artery bypass grafting ( CABG).In the practice,patients with serious coronary artery stenosis prefer to choose PCI, es-pecially SYNTAX score or guidelines of treatment patients with multivessel disease are more recommended to choose CABG.However, disad-vantages of CABG are severe surgical trauma and complications, similarly,PCI also has complications with stent restenosis and thrombosis e-vent.With the development of medical technology, hybrid coronary revascularization is coming out.This article is reviewing the definition, patient selection strategies,and new research progress of hybrid coronary revascularization.